Corruption is considered to be one of the biggest barriers to human development and economic growth. Corruption is without borders; it can be found in any country, in different forms, levels, and types of organizations and institutions. In the health sector annually, an estimated $5.3 trillion is spent worldwide on providing health services, yet as much as 6 percent or $300 billion USD is lost to corruption and errors according to the World Health Organization. Corruption negatively impacts public health budgets, the price of health services and medicines, and the quality of care and medical products; as well, it threatens a country’s ability to provide universal health coverage by increasing the price of health care.
This one day seminar will provide an opportunity for health care professionals and researchers to gain a deeper understanding of how corruption and lack of good governance can have an impact on pharmaceutical services and importantly provide strategies and tactics to educate participants on how to counter vulnerabilities within the sector.
- To introduce and discuss concepts of governance and corruption and explain how they relate to the pharmaceutical sector
- To educate participants on how to identify potential areas of weak governance that can lead to poor results in pharmaceutical services
- To highlight anti‐corruption initiatives, strategies and tactics relevant to the pharmaceutical sector
For more information please contract: firstname.lastname@example.org.